BREATHE – B cell Receptor Evaluation for Antibodies to protect Human Exposure to SARS-CoV-2

Project Details

Short titleBREATHE – B cell Receptor Evaluation for Antibodies to protect Human Exposure to SARS-CoV-2
StatusFinished
Effective start/end date1/07/2030/06/21

Funding

  • Alchemab Therapeutics Ltd